Surprisingly High Hypercortisolism Prevalence With Uncontrolled Type 2 Diabetes Many also had adrenal abnormalities Jun 25, 2024
Large-Scale Intensive BP Intervention Proves Sustainable for CVD Prevention Community-based program reduced events regardless of age, diabetes Jun 18, 2024
Train Eyes So Myopia Doesn't Get Worse? Nurse Intervention for BP Post-Stroke Also in TTHealthWatch: cancers subsequent to CAR-T therapy Jun 15, 2024 podcast
Postpartum Readmissions Up With High Blood Pressures Lingering From Pregnancy Concerns about BP thresholds for antihypertensive medication initiation Jun 12, 2024
Increased Heart Risks With Newer Prostate Cancer Drugs, Meta-Analysis Shows Adding ARSIs to ADT for advanced disease doubled the risk of high-grade CV events, death Jun 06, 2024
Better Cognitive Outcomes Tied to Vigorous Exercise in Hypertensive Adults SPRINT MIND analysis looks at 7,600 older adults at high risk of cognitive decline Jun 06, 2024
Hypertension After Kidney Donation; Statins in Old and Very Old People Also in TTHealthWatch: fluoride's effect on pregnancy outcomes Jun 01, 2024 podcast
Draw Between Two Diuretics for Renal Prevention in Hypertension But researcher questions if patients were underdosed May 16, 2024
Novel Biannual Antihypertensive Shows Potential for Combination Therapy Drug might be most effective with a diuretic, according to suggestive data from a phase II trial Apr 09, 2024
Oral Appliance for Sleep Apnea Noninferior to CPAP for Reducing Arterial BP For patients with hypertension, oral device may be an option for those who cannot tolerate CPAP Apr 09, 2024
Primary Care Strategy Fails to Reduce Kidney-Dysfunction Triad Hospitalizations Secondary outcomes also showed no significant differences Apr 03, 2024
Sotatercept's FDA Approval a New Chapter for Pulmonary Arterial Hypertension Biologic should arrive on pharmacy shelves before May Mar 27, 2024
Fixed-Dose Macitentan/Tadalafil Combo Gets FDA Approval for PAH Opsynvi puts two drugs commonly prescribed for pulmonary arterial hypertension into one tablet Mar 25, 2024
Novel Oral Antihypertensive Gets FDA's Blessing Aprocitentan becomes the first endothelin receptor antagonist for BP lowering Mar 20, 2024
EHR Alerts Trigger Primary Care Clinics to Improve Hypertension Care in CKD Greater reduction in systolic BP over usual care in randomized trial Mar 15, 2024
Deaths Due to Alcohol Use; Steps for the Sedentary Also in TTHealthWatch: microplastics in arteries, and worldwide obesity and diabetes risk Mar 09, 2024 podcast
Interventions Can Reduce CVD Risk Factors in HIV Patients, Studies Show Lowering blood pressure, cholesterol prove feasible in randomized trials Mar 07, 2024
Primordial Prevention Can Protect Black Women's Cardiovascular Health Let's block the risk factors before they start Feb 19, 2024
Hypertension, Diabetes in Pregnancy Affects Offspring's Heart Health in Adolescence Hypertensive disorders of pregnancy and gestational diabetes are both on the rise Feb 16, 2024
RNA Silencer Zilebesiran: Infrequent Injections Bring Down BP Sustained BP reductions seen in early trial whether patients got one or two doses in 6 months Feb 16, 2024
Tirzepatide's Association With BP Reduction Reinforced With ABPM Data Combination GLP-1/GIP receptor agonist is currently approved for T2D and weight loss Feb 05, 2024
Health Record Trigger Boosted Screening for Primary Aldosteronism Best-practice advisory tested in adults with hypertension Jan 08, 2024
Is Your Patient Married? Check Their Spouse's Blood Pressure, Too Couple-centered strategies can help manage hypertension Dec 18, 2023
High-Altitude Mountain Trips Can Be Tolerated Despite Pulmonary Hypertension Effects of high elevation tested in an experiment in the Swiss Alps Dec 12, 2023
Doc Set Home on Fire? High Blood Pressure in Couples; WHO: Raise Alcohol, Soda Taxes Health news and commentary from around the Web gathered by staff Dec 06, 2023
High Blood Pressure in Babies Linked to Adult Atherosclerosis Is BP screening starting before age 3 years warranted? Dec 04, 2023
Coronary Heart Disease by Age 45 Linked With Subsequent Dementia All-cause dementia, Alzheimer's disease, and vascular dementia risks elevated Nov 29, 2023
Live Shingles Vaccine and Waning Immunity; Semaglutide and CV Events Also in TTHealthWatch: sodium and blood pressure; aspirin and LVADs Nov 18, 2023 podcast
Lowering the Target for Blood Pressure Is Best, Study Affirms Huge trial from China reinforces the message from SPRINT for higher-risk hypertensive patients Nov 13, 2023
Intensive Blood Pressure Lowering Cuts Dementia Risk Benefit finally proven in clinical trial Nov 12, 2023
Antihypertensives Do Not Detract From the BP Reduction of a Low-Sodium Diet Dietary change produces clinically relevant BP changes within a week Nov 12, 2023
FDA Approves First Renal Denervation System for Hypertension Catheter-based technology will finally enter the market with ultrasound-based device Nov 08, 2023
Kidney Week Roundup: Cell Therapy Cuts Immunosuppressive Drug Use Post-Transplant Plus: bardoxolone methyl for diabetic kidney disease and spironolactone in hemodialysis patients Nov 07, 2023
Heart Injuries Suggest Reconsideration of Holding BP Meds for Surgery Pause on ACE inhibitors, ARBs yields more acute hypertension with no prevention of hypotension Nov 06, 2023
Pharmacist Prescribing for BP Control Makes Economic Sense Clinical benefits of pharmacist-prescribed antihypertensives known for years Nov 03, 2023
'Surprising' Contribution of Pulmonary Hypertension to ARDS Outcomes Coexisting conditions spell markedly poor clinical course Oct 12, 2023
Time to Recognize Cardiovascular-Kidney-Metabolic Syndrome, AHA Says Pooled cohort equations will make way for new CKM risk calculator Oct 09, 2023
Adherence Matters for CVD Secondary Prevention in CPAP Users Questionable benefit may hinge on number of hours used Oct 05, 2023
Is Being a Night Owl Unhealthy? CRC Screening Not Recommended Enough Also in TTHealthWatch: CVD death and obesity Sep 16, 2023 podcast
Lorundrostat Stands a Chance Against Obesity-Related Hypertension Selective aldosterone synthase inhibitor proceeds to phase III study after Target-HTN's success Sep 10, 2023